Fair enough! If you hold this stock for the next 12 months don't be surprised if it's $1 plus. Covata will be a 2017 story.
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game